关键信息
-
基因名
TRBC2
- 应用
-
别名
TCRBC2
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A5B9
-
表达区间
1-129aa
-
分子量
19.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
TRBC2 (T-cell receptor beta constant region 2) is a crucial component of the T-cell receptor (TCR) complex, which plays a vital role in the immune response by recognizing antigens. Research into TRBC2 recombinant protein has gained significant attention due to its potential applications in immunotherapy, vaccine development, and understanding T-cell biology. TCRs are composed of variable and constant regions, with the beta chain being essential for recognizing peptide-MHC complexes presented by antigen-presenting cells. Recombinant TRBC2 protein can provide insights into TCR signaling pathways, enhance T-cell functionality, and facilitate the study of T-cell development and differentiation. Additionally, generating recombinant TRBC2 allows researchers to explore its structural and functional properties, paving the way for novel therapeutic strategies against cancer and infectious diseases. The ability to produce TRBC2 in a laboratory setting also enables the design of TCRs with improved specificity and affinity, which are critical for the success of T-cell therapies. As the field of immunology continues to evolve, understanding the role of TRBC2 and its recombinant forms may lead to advancements in personalized medicine and immune modulation, addressing pressing health challenges.
